크기 선택
제품정보 (DICE 배송 시 비용 별도)
Quality Level
agency
BP, JP, Ph. Eur., USP
product line
EMPROVE® API
form
solid
potency
>8000 mg/kg LD50, oral (Rat)
pH
7.5-9.0 (25 °C, 50 g/L in H2O)
mp
150 °C (anhydrous substance), >300 °C (lit.)
solubility
720 g/L
bulk density
600 kg/m3
application(s)
liquid formulation
parenterals
pharma/biopharma processes
pharmaceutical
solid formulation
storage temp.
2-25°C
SMILES string
O.O.[Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
InChI
1S/C6H8O7.3Na.2H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;2*1H2/q;3*+1;;/p-3
InChI key
NLJMYIDDQXHKNR-UHFFFAOYSA-K
General description
Application
Legal Information
저장 등급
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
시험 성적서(COA)
제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.
문서
Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.
관련 콘텐츠
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.
국제 무역 품목 번호
| SKU | GTIN |
|---|---|
| 1066669029 | 04027269575038 |
| 1066661000 | 04027269670535 |